A poly(glycerol–sebacate–curcumin) polymer with potential use for brain gliomas
- 31 August 2012
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 101A (1) , 253-260
Abstract
Curcumin has multiple biological and pharmacological activities, including antioxidant, anti‐inflammatory, antiviral, antibacterial, antifungal, and antitumor activities. However, the clinical use of curcumin is limited because of its poor oral absorption and extremely poor bioavailability. In order to overcome these limitations, we conjugate curcumin chemically into the known biocompatible and biodegradable polymer, poly(glycerol–sebacate), and prepare the unitary poly(glycerol–sebacate–curcumin) polymer. The structure, the in vitro degradation, the drug release, and antitumor activity as well as the in vivo degradation and tissue biocompatibility of poly(glycerol–sebacate–curcumin) polymer are investigated. The in vitro degradation and drug release profile of poly(glycerol–sebacate–curcumin) are in a linear manner. The in vitro antitumor assay shows that poly(glycerol–sebacate–curcumin) polymer significantly inhibits human malignant glioma cells, U87 and T98 cells. In view of the cytotoxicity against brain gliomas, local use of this polymer would be a potential method for brain tumors. © 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 101A:253–260, 2013.Keywords
This publication has 15 references indexed in Scilit:
- Curcumin as a therapeutic agent: the evidence fromin vitro, animal and human studiesBritish Journal of Nutrition, 2010
- The application of poly (glycerol–sebacate) as biodegradable drug carrierBiomaterials, 2009
- Curcumin and Cancer Cells: How Many Ways Can Curry Kill Tumor Cells Selectively?The AAPS Journal, 2009
- Curcumin blocks brain tumor formationBrain Research, 2009
- Glycolic acid modulates the mechanical property and degradation of poly(glycerol, sebacate, glycolic acid)Journal of Biomedical Materials Research Part A, 2009
- An in vitro study of liposomal curcumin: Stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B-cellsInternational Journal of Pharmaceutics, 2009
- Liposome-Encapsulated Curcumin Suppresses Growth of Head and Neck Squamous Cell CarcinomaIn vitroand in Xenografts through the Inhibition of Nuclear Factor κB by an AKT-Independent PathwayClinical Cancer Research, 2008
- Bioavailability of Curcumin: Problems and PromisesMolecular Pharmaceutics, 2007
- Curcumin induces G2/M cell cycle arrest in a p53-dependent manner and upregulates ING4 expression in human gliomaJournal of Neuro-Oncology, 2007
- Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP‐1 and NFκB transcription factorsJournal of Neurochemistry, 2007